Join us for a clinical review of the definitions, incidence, prevalence, risk factors, co-morbidities, and clinical signs & symptoms of dry eye and ocular surface disease, followed by a discussion of new and emerging therapeutic interventions.  Recently approved pharmaceuticals, interventional procedures, and medical devices, as well as pipeline therapies in various stages of development, will be presented in a fast-paced, multimedia format.